Top 5 Trending Canadian Stocks Today

The Canadian markets are seeing their own set of trending stocks, from large TSX stalwarts to surging junior miners. According to Yahoo Finance Canada, these five Canadian-listed names are attracting outsized attention today. Let’s dive into what’s driving each of these trending tickers.

1. Constellation Software (CSU.TO) – Founder’s Exit Shakes the Market

Tech conglomerate Constellation Software is front and center on Bay Street today. The $50+ billion Toronto-based software acquirer saw its stock fall sharply, landing it atop the trending list, after an announcement about its legendary founder.

• Founder Resigns: Constellation revealed that President and founder Mark Leonard is stepping down due to health reasons. Leonard’s departure is significant – he’s revered for guiding Constellation’s decades-long stellar growth. The news caught investors off-guard.
• Stock Reacts: Shares of CSU tumbled ~5–6% on the announcement, dropping to about C$3,910 by midday. This decline wiped out roughly $4.8 billion in market value. For a normally steady stock, that’s a big move, sparking heavy trading volume as funds and traders recalibrated their outlook.
• Why It’s Trending: Mark Leonard’s resignation represents the end of an era, raising questions about Constellation’s future leadership (a successor was named internally). The stock’s swoon also dragged down the TSX index. A high-profile leadership change combined with an unusually large price drop made Constellation Software the talk of the Canadian market today.

2. Hemostemix Inc. (HEM.V) – Stem Cell Innovator Gaining Traction

Hemostemix, a tiny TSX Venture-listed biotech, has been climbing up the trending ranks thanks to a series of promising developments. The Calgary-based company specializes in autologous blood-derived stem cell therapy (ACP-01), and recent news has traders buzzing.

• Regulatory Progress: Hemostemix filed an FDA Pre-IND submission to launch a “basket” clinical trial of its lead stem cell therapy across multiple ischemic conditions. This could accelerate U.S. trials for treating heart disease, peripheral artery disease, vascular dementia and more – a broad potential market.
• Commercial Breakthrough: The company is already taking advantage of a new Florida law that allows use of its stem-cell treatment for patients who have exhausted standard options. Hemostemix has begun offering its VesCell™ therapy in Florida under Senate Bill 1768, marking a milestone in commercialization. This “boots on the ground” approach means revenue-generating treatments have started even before full FDA approval.
• Why It’s Trending: Hemostemix’s stock, while still penny-stock cheap (~$0.07), has attracted attention due to these catalysts. The combination of real-world patient treatments and forward-looking trial plans is unusual for a microcap biotech. Investors see a path to monetization (Florida patients and partnerships) alongside long-term upside if FDA trials succeed. That mix of near-term and long-term potential has put HEM.V squarely on the Canadian trending stock list.

3. Aurora Solar Technologies (ACU.V) – Penny Stock Doubles on High Volume

Aurora Solar Technologies, a Vancouver-based solar equipment company, is an unlikely star on the trending tickers – its stock price literally doubled overnight. This TSX Venture-listed firm, which provides quality-control systems for solar cell manufacturing, suddenly caught traders’ attention with a price jolt.

• Stock Spike: ACU.V jumped from $0.01 to $0.02 in a single trading session. While that’s just a one-cent move, it represents a +100% gain. The day’s trading range (from $0.015 to $0.02) and the surge to the stock’s highest level in months signaled that something was afoot.
• Possible Catalysts: The rally appears to be momentum-driven, as there were no widely publicized news releases that day. However, Aurora Solar had recently issued its annual results and a corporate update, and at 1–2 cents, the stock is highly speculative. It’s possible that speculators seized on optimistic commentary about the company’s partnership with BT Imaging (a June announcement of an “Intelligent PL” solar tech platform win) or the completion of a financing facility, betting on a turnaround.
• Why It’s Trending: It’s all about the dramatic percentage move. A triple-digit percentage pop on huge volume is the hallmark of a trending penny stock. Aurora Solar’s market cap is only ~$4 million, so it doesn’t take much new buying to move the needle. Today’s spike put ACU.V on many traders’ radar screens, as they scan for the next big solar or green-energy microcap play.

4. Masivo Silver Corp. (MASS.V) – Junior Miner Near 52-Week Highs

Masivo Silver, a junior mining company, has climbed into the trending ranks thanks to heightened interest in its exploration story. Listed on the TSX Venture, Masivo is focused on precious metals projects in Mexico and Nevada – and traders have zeroed in on its recent activity.

• Project Momentum: The company recently highlighted historically high-grade drill results from its newly acquired Cerro Colorado gold-silver property in Mexico. In June, Masivo reported encouraging grades from old drill holes and simultaneously announced an equity raise to fund exploration. It’s also proceeding with a new drill program at Cerro Colorado as of this spring.
• Stock Near Highs: MASS.V has been trading up into the 0.09–0.10 range (9 to 10 cents), which is around its 52-week high. Just last week, the stock pulled back to $0.075 on some profit-taking. but renewed interest now has it retesting the top of its range. Investors appear optimistic that pending drill results or an upcoming audit update (the company expects to file delayed financials by the end of September) could be positive.
• Why It’s Trending: Masivo Silver combines two ingredients beloved by Canadian small-cap enthusiasts: precious metals potential and volatility. With gold prices firm and Masivo actively drilling and acquiring new claims, the stock has a speculative buzz around it. Its trading volume and chat room mentions have jumped as it flirts with multi-month highs. In short, MASS.V is trending because many see it as a cheap leverage play on exploration news – with a “lottery ticket” flavor typical of junior miners.

5. Daura Gold Corp. (DGC.V) – Expanding Gold Explorer in the Spotlight

Rounding out the list is Daura Gold, another TSX Venture-listed junior miner that’s gaining attention. Daura is exploring gold-silver projects in Peru, and it has made a series of strategic moves that haven’t gone unnoticed by the market.

• Aggressive Expansion: This summer, Daura Gold closed the acquisition of the Yanamina epithermal gold-silver project in Ancash, Peru, adding a 900-hectare high-grade target to its portfolio. Shortly before that, it inked a deal to acquire five strategic claims adjacent to its existing Antonella and Bonita project areas. These moves greatly expanded Daura’s land position (now over 8,100 ha in total) in a region known for rich gold deposits.
• Growing Buzz: With new properties in hand, Daura has ramped up exploration and even engaged third-party investor relations to tell its story. Traders have taken note – the stock has been trading active volumes, and an investorhub post even touted a “new high-grade silver-gold vein” discovery at Antonella (unverified, but illustrative of the chatter).
• Why It’s Trending: Daura Gold checks the trend boxes as a high-impact exploration play. It is now cashed up (via recent financings) and actively drilling in a mining-friendly jurisdiction. The stock, hovering in the mid-teens cents, has shown bursts of activity whenever news hits. The prospect that Daura might delineate a significant gold resource has speculators engaged. In a market that loves growth-by-acquisition and big drill results, DGC.V’s steady stream of news and project expansion has earned it a spot among the top trending Canadian stocks.

From Constellation Software’s boardroom news to penny mining stocks on the Venture exchange, Canada’s trending stocks today span a broad spectrum. Each is trending for a distinct reason – whether it’s a leadership change, biotech progress, or drilling excitement. As always, investors should keep an eye on the underlying developments (cited above) driving these moves, as today’s market darlings can become tomorrow’s afterthoughts once the headlines pass.

Disclosure: Lusso’s News, LLC(“EMV”) has been compensated by Hemostemix Inc. (“Hemostemix”) in the amount of $5,000 USD per month, commencing August 13, 2025, and continuing through September 31, 2025, with the possibility of extension until further notice. This compensation is for the creation and dissemination of content about Hemostemix, including but not limited to articles, website postings, social media updates, and other promotional materials. The content produced by EMV is intended solely for informational purposes. It does not constitute an offer to sell, a solicitation to buy, or a recommendation regarding any security, investment product, or trading strategy. EMV is not a registered investment adviser or broker-dealer, and nothing in this content should be construed as personalized investment advice. Investing in securities involves risks, including the potential loss of principal. Readers should conduct their own independent research, perform due diligence, and consult with a licensed financial adviser, attorney, or tax professional before making any investment decisions.